Stay updated with breaking news from Kind Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Liquidia Corp. moved closer to gaining final regulatory approval for its Yutrepia drug as a US appeals court rejected United Therapeutics Corp.'s attempt to revive a patent for Tyvaso that an administrative tribunal canceled.
“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Shares of MannKind (NASDAQ:MNKD) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 25.00% over ...